Cell-Free Circular Nucleic Acid Amplification for High-Purity Synthesis

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods for producing synthetic nucleic acid molecules are costly, require expensive equipment, and result in impure products due to cell-mediated amplification, with difficulties in controlling fidelity and expression.

Innovation Solution

A cell-free method for amplifying synthetic circular nucleic acids using endonucleases, ligases, and topoisomerases to produce high-purity products, eliminating the need for cell-based systems and reducing impurities.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Quantity of substance

If cell-based systems are used to amplify synthetic nucleic acid molecules, then adequate quantities of NA molecules can be produced, but the resulting NA molecules contain impurities from the cell system and require expensive specialized equipment

Engineering Contradiction:
Improvequantity of synthetic NA moleculesVSAvoidimpurities from cell system
Core Design Contradiction:
Quantity of substanceVSObject-generated harmful factors

Solution Approach 1:

The patent extracts the nucleic acid amplification process from the cell-based system and performs it in a cell-free manner using purified enzymes. This removes the harmful impurities introduced by cell systems while maintaining the ability to produce adequate quantities of synthetic NA molecules through controlled enzymatic reactions.

Inventive Principle:
Principle #2Taking out (Extraction)

Solution Approach 2:

The patent replaces the complex cell-based biological system with a simplified enzymatic system. Instead of using living cells for amplification, the invention employs purified polymerases and other enzymes in a controlled biochemical reaction, eliminating the mechanical and biological complexity of cell culture while reducing impurities.

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

2Quantity of substance

If cell-based systems are used for NA amplification, then production can be achieved, but it is difficult to control fidelity and expression

Engineering Contradiction:
Improveproduction of synthetic NA moleculesVSAvoidfidelity and expression control
Core Design Contradiction:
Quantity of substanceVSManufacturing precision

Solution Approach 1:

The patent incorporates feedback mechanisms through carefully controlled enzymatic reactions with specific polymerases that proofread and correct errors during amplification. This ensures high fidelity reproduction of the synthetic NA molecules while maintaining production efficiency, as the enzymatic system self-corrects to maintain sequence accuracy.

Inventive Principle:
Principle #23Feedback

Solution Approach 2:

The patent optimizes reaction parameters such as temperature, pH, enzyme concentrations, and reaction time to achieve precise control over amplification fidelity and expression. By adjusting these parameters, the system maintains high production levels while ensuring accurate replication of the synthetic NA molecules without the variability introduced by cell-based systems.

Inventive Principle:
Principle #35Parameter changes

3Quantity of substance

If cell-based systems are used for NA production, then adequate quantities can be generated, but the methods require expensive specialized equipment

Engineering Contradiction:
Improvequantity of synthetic NA moleculesVSAvoidexpensive specialized equipment
Core Design Contradiction:
Quantity of substanceVSDevice complexity

Solution Approach 1:

The patent extracts the essential amplification function from complex cell-based systems and implements it through simple enzymatic reactions. This eliminates the need for expensive specialized equipment such as cell culture facilities, incubators, and complex purification systems, while still producing adequate quantities of synthetic NA molecules.

Inventive Principle:
Principle #2Taking out (Extraction)

Solution Approach 2:

The patent uses disposable reagents and enzymes in a cell-free system, replacing the need for expensive, maintainable cell culture infrastructure. The enzymatic components can be easily discarded after use, eliminating the need for costly specialized equipment while maintaining production capability.

Inventive Principle:
Principle #27Cheap short-living objects (Disposable)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The method provides cost-effective, high-purity, and efficient synthesis of circular nucleic acids, avoiding cell-mediated impurities and enabling faster, more controlled amplification processes.

Implementation Method 1

contacting the amplification product with a first endonuclease under conditions for digestion, thereby producing a first digestion product

Methodology Applied
Scientific EffectEndonuclease digestion: Enzyme

Implementation Method 2

adding the first digestion product to a ligation reaction mixture comprising a ligase enzyme; and incubating the ligation reaction mixture, thereby producing a circular ligation product

Methodology Applied
Scientific EffectLigation: Enzyme

Implementation Method 3

contacting the circular ligation product with a topoisomerase under conditions that promote supercoiling, thereby producing a supercoiled product

Methodology Applied
Scientific EffectSupercoiling: Enzyme

Data Source

PatentUS12509719B2Cell-free method of producing synthetic circular nucleic acid
Publication Date: 2025.12.30 ALDEVRON LLC
  • US12509719B2 patent drawing
  • US12509719B2 patent drawing
  • US12509719B2 patent drawing

AI summary

The present disclosure relates to a process of cell-free circular nucleic acid amplification using rolling circle amplification.